Abiopharma

New Form 8-K/A - Processa Pharmaceuticals, Inc. Filed: 2025-08-14 AccNo: 0001641172-25-023736 Size: 489 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits